Some US Employers Plan to Drop GLP-1 Coverage for Obesity in 2027, Reuters Reports

Robust Phase 2B Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s Glp-1 Ra Berobenatide

Hims Exec Says Company Incurred About $33 Mln in Restructuring Costs Tied to Glp-1 Supply Chain Write-Downs - Conf Call

Amazon Pharmacy Expands Access to New Ozempic® Pill via Same-Day Delivery, Kiosks

Eli Lilly Q1 Revenue Soars 56%, GLP-1 Drug Sales Nearly Double, Full-Year Guidance Raised

Boehringer: Weight Loss of 16.6% in Survodutide Group After 76 Weeks Compares With 3.2% in Placebo Group

Boehringer Ingelheim: Survodutide Drug Candidate Led to Weight Loss of up to 16.6% in Phase Iii Trial Synchronize-1

Trump Administration Is Indefinitely Delaying a Medicare Pilot Program to Cover Weight-Loss Drugs- Axios

BRIEF-Trump Administration Is Indefinitely Delaying A Medicare Pilot Program To Cover Weight-Loss Drugs- Axios

Health insurers raise questions about Medicare program that will offer GLP-1s to seniors for $50

Amazon Launches GLP-1 Weight-Management Program

BRIEF-Amazon One Medical Launches National GLP-1 Management Program With Amazon Pharmacy Integration

Amazon One Medical: One Medical Also Developed an Electronic Model to Streamline Insurance Prior Authorization Process for Glp-1 Medications

Walmart Expands Access to Weight Management Support Services for Customers on or Exploring Glp-1S

Website Says Many Commonly Prescribed Brand-Name Drugs Are Listed on Trumprx, Such as Fertility and Weight Loss Drugs

FDA: Initial Review of Glp-1 Ra Clinical Trial Data Did Not Find an Association Between the Use of Glp-1 Ras and the Occurrence of Si/B